The updated ISHLT guidelines incorporate interval advancements in medical therapies and new approaches in the evaluation and management of children with heart failure.
Pediatric heart failure (HF) secondary to cardiomyopathies, acquired heart disease, and congenital heart disease is associated with significant morbidity and mortality. These guidelines represent an update from the International Society for Heart and Lung Transplantation guidelines for the management of pediatric HF that were published in 2014 and incorporate interval advancements in medical therapies and new approaches in the evaluation and management of children with HF.
Irving et al. (2025) conducted a review in Pediatric heart failure. Guidelines for the management of pediatric heart failure was evaluated. The updated ISHLT guidelines incorporate interval advancements in medical therapies and new approaches in the evaluation and management of children with heart failure.